LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
Clinical trial NCT04759664 · UNKNOWN
Trial details
- NCT number
- NCT04759664
- Sponsor
- Lutris Pharma Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-12
- Primary completion
- 2024-03-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.